Endeavor BioMedicines Reports Results from the P-IIa Study of ENV-101 for Treating Idiopathic Pulmonary Fibrosis
Shots: The
Shots: The P-IIa (AIR) study assessed the safety, tolerability & efficacy of b...
Shots: HUTCHMED has reported the P-III (
Shots: The P-III (
Shots: The P-III (QWINT-2 & QWINT-4) studies assess the safety & efficacy...
Shots: The P-I (CT-388-101) study assesses the safety, tolerability & PK/PD of...
Incisive News in 3 Shots.